Respiratory News and Research

RSS

Mail-order prescriptions exposed to excessive heat may become significantly less effective for patients

Mail-order prescriptions exposed to excessive environmental heat, such as temperatures found in mailboxes and car interiors, may become significantly less effective for patients.

28 Oct 2004

British Government report declares NHS accident and emergency, the envy of the world

With 96 per cent of patients being seen and treated quickly in NHS A&E departments, this country's emergency departments are becoming the envy of the world, according to a British Government Report.

26 Oct 2004

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

Using nonprescription, or over-the-counter (OTC), medications to treat common upper respiratory infections could save $4.75 billion a year, according to a new study conducted by researchers from Northwestern University.

26 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Researchers identify a protein that could banish allergies

The suffering of millions of people with allergies could one day be eased thanks to new research from UK investigators. Findings from the University College London branch of the Ludwig Institute for Cancer Research (LICR), published in the Oct 2004 issue of Nature, detail how inactivating a key signalling molecule called p110delta reduced the effect of allergies on mice.

21 Oct 2004

New antibody to prevent respiratory syncytial virus in premature babies

Virginia Commonwealth University researchers are studying the effectiveness of introducing a new antibody in premature infants to manage the most common form of lower respiratory tract infections in children worldwide.

21 Oct 2004

Small delay after birth when cutting umbilical cord of a premature baby appears to lessen chances of bleeding

Waiting 30 seconds to two minutes after birth to cut the umbilical cord of a premature baby appears to lessen chances of bleeding in the newborn’s brain and reduce the need for transfusions, according to a new review of research.

18 Oct 2004

Asthma research company Synairgen to float on London's Alternative Investment Market

A spin-out company from the University of Southampton specialising in finding and out-licensing treatments for chronic bronchitis (COPD) and the severest forms of asthma, is about to seek a listing on London's Alternative Investment Market (AIM).

13 Oct 2004

Researchers help neonatal specialists administer a replacement substance that helps babies breathe easier

When babies are born prematurely, their lungs are not able to produce a protein that helps them breathe.

13 Oct 2004

New Jersey to receive additional flu vaccine

The New Jersey Department of Health and Senior Services (DHSS) received information on October 5, 2004 that, due to manufacturing problems in the United Kingdom, the United States will have only one-half of the expected supply of the influence vaccine available for this year’s flu season.

13 Oct 2004

Wisconsin has identified its first laboratory confirmed case of influenza this season

Public health officials in the department said the case, confirmed by the Wisconsin State Laboratory of Hygiene to be influenza type A (H3 subtype), involves an adult female from Waupaca County.

13 Oct 2004

Surgical remedies for snoring and sleep disorders

Like thousands of Americans, snoring keeps Dr. Kenny Pang awake at night. It’s not his own nocturnal nasal sounds, or those of his wife, that trouble Dr. Pang -- it’s the why behind the sounds.

13 Oct 2004

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

MedImmune has announced that data from a preclinical study for its lead vaccine candidate to prevent respiratory syncytial virus (RSV) and parainfluenza virus type-3 (PIV-3) has shown a protective immune response against both viruses in animals.

13 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Dr. Eric E. Whitaker, Illinois state public health director, is encouraging health care providers to work together to ensure that high-risk individuals get the flu shot.

11 Oct 2004

Respiratory therapists are at an increased risk of developing asthma

Respiratory therapists are at an increased risk of developing asthma and asthma-related symptoms due to their involvement in the diagnosis and treatment of patients with respiratory conditions.

11 Oct 2004

Exposure to tobacco smoke and pollutants increases childhood risk of asthma

Children prenatally exposed to pollutants, such as motor vehicle exhaust, and postnatally exposed to environmental tobacco smoke (ETS) may be more likely to suffer from asthma and related symptoms early in life.

11 Oct 2004

Global under-five death rate far below targets agreed to by world leaders

New country-by-country data reveals alarmingly slow progress on reducing child deaths despite the availability of proven, low-cost interventions, a UNICEF survey revealed today.

8 Oct 2004

Researchers have found a starting point to establishing the genetic basis for sinus disease

In a three-year analysis of more than 10,500 genes, one-third of the human genome, researchers at Johns Hopkins have found a starting point to establishing the genetic basis for sinus disease and the growth of nasal polyps, illnesses not well understood despite their prevalence.

8 Oct 2004

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

Influenza (or as it is commonly known, the flu) is a contagious disease caused by an RNA virus of the orthomyxoviridae family (The orthomyxoviridae is a family of RNA viruses which infect vertebrate).

6 Oct 2004

Respiratory News and Research

Mail-order prescriptions exposed to excessive heat may become significantly less effective for patients

British Government report declares NHS accident and emergency, the envy of the world

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

Researchers identify a protein that could banish allergies

New antibody to prevent respiratory syncytial virus in premature babies

Small delay after birth when cutting umbilical cord of a premature baby appears to lessen chances of bleeding

Asthma research company Synairgen to float on London's Alternative Investment Market

Researchers help neonatal specialists administer a replacement substance that helps babies breathe easier

New Jersey to receive additional flu vaccine

Wisconsin has identified its first laboratory confirmed case of influenza this season

Surgical remedies for snoring and sleep disorders

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Respiratory therapists are at an increased risk of developing asthma

Exposure to tobacco smoke and pollutants increases childhood risk of asthma

Global under-five death rate far below targets agreed to by world leaders

Researchers have found a starting point to establishing the genetic basis for sinus disease

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News